Waldencast PLC (NASDAQ:WALD) Short Interest Update

Waldencast PLC (NASDAQ:WALD - Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 402,600 shares, a growth of 26.2% from the May 15th total of 318,900 shares. Currently, 3.4% of the shares of the stock are short sold. Based on an average daily volume of 96,300 shares, the short-interest ratio is currently 4.2 days.

Institutional Investors Weigh In On Waldencast

Several hedge funds have recently added to or reduced their stakes in the business. Stonebrook Private Inc. acquired a new position in Waldencast in the 4th quarter valued at approximately $48,000. Ethic Inc. bought a new stake in shares of Waldencast in the fourth quarter worth $56,000. Wells Fargo & Company MN increased its holdings in Waldencast by 29.9% in the fourth quarter. Wells Fargo & Company MN now owns 14,571 shares of the company's stock valued at $59,000 after purchasing an additional 3,358 shares during the period. XTX Topco Ltd acquired a new stake in Waldencast in the fourth quarter valued at $70,000. Finally, Jane Street Group LLC bought a new position in Waldencast during the 1st quarter worth $77,000. 41.97% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

WALD has been the topic of several recent analyst reports. DA Davidson reiterated a "buy" rating and issued a $7.50 price target on shares of Waldencast in a research note on Wednesday, March 19th. Telsey Advisory Group lowered their target price on Waldencast from $5.00 to $4.00 and set an "outperform" rating for the company in a research note on Thursday, May 15th. Wall Street Zen cut shares of Waldencast from a "hold" rating to a "sell" rating in a report on Thursday, May 22nd. Canaccord Genuity Group reduced their price target on shares of Waldencast from $6.00 to $5.00 and set a "buy" rating on the stock in a research note on Thursday, May 15th. Finally, Industrial Alliance Securities set a $5.00 price objective on shares of Waldencast in a research report on Tuesday, April 22nd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $5.11.

Waldencast Price Performance

Shares of WALD stock opened at $2.15 on Wednesday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.35 and a quick ratio of 0.66. The business's 50-day moving average price is $2.53 and its 200-day moving average price is $3.02. Waldencast has a 12 month low of $1.98 and a 12 month high of $4.74.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.